» Articles » PMID: 28609209

Creation of a Human T-ALL Cell Line Online Database

Overview
Journal Leuk Lymphoma
Specialties Hematology
Oncology
Date 2017 Jun 14
PMID 28609209
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

NUP98-BPTF promotes oncogenic transformation through PIM1 upregulation.

Noura M, Tomita S, Yasuda T, Tsuzuki S, Kiyoi H, Hayakawa F Cancer Med. 2024; 13(13):e7445.

PMID: 38940430 PMC: 11212001. DOI: 10.1002/cam4.7445.


Adipocyte-mediated epigenomic instability in human T-ALL cells is cytotoxic and phenocopied by epigenetic-modifying drugs.

Lee M, Geitgey D, Hamilton J, Boss J, Scharer C, Spangle J Front Cell Dev Biol. 2022; 10:909557.

PMID: 36060800 PMC: 9438935. DOI: 10.3389/fcell.2022.909557.


Autophagy Regulates VDAC3 Ubiquitination by FBXW7 to Promote Erastin-Induced Ferroptosis in Acute Lymphoblastic Leukemia.

Zhu T, Liu B, Wu D, Xu G, Fan Y Front Cell Dev Biol. 2021; 9:740884.

PMID: 34869326 PMC: 8634639. DOI: 10.3389/fcell.2021.740884.


Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia.

Xi M, Guo S, Bayin C, Peng L, Chuffart F, Bourova-Flin E Front Med. 2021; 16(3):442-458.

PMID: 34669156 DOI: 10.1007/s11684-021-0877-y.


hsa-miR-20b-5p and hsa-miR-363-3p Affect Expression of and Tumor Suppressor Genes and Modulate Survival of T-ALL Cells In Vitro.

Drobna M, Szarzynska B, Jaksik R, Sedek L, Kuchmiy A, Taghon T Cells. 2020; 9(5).

PMID: 32380791 PMC: 7290785. DOI: 10.3390/cells9051137.

References
1.
Lorsch J, Collins F, Lippincott-Schwartz J . Cell Biology. Fixing problems with cell lines. Science. 2014; 346(6216):1452-3. PMC: 5101941. DOI: 10.1126/science.1259110. View

2.
Coustan-Smith E, Mullighan C, Onciu M, Behm F, Raimondi S, Pei D . Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 2009; 10(2):147-56. PMC: 2840241. DOI: 10.1016/S1470-2045(08)70314-0. View

3.
Drexler H, Dirks W, Matsuo Y, MacLeod R . False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia. 2003; 17(2):416-26. DOI: 10.1038/sj.leu.2402799. View

4.
Ferrando A, Neuberg D, Staunton J, Loh M, Huard C, Raimondi S . Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002; 1(1):75-87. DOI: 10.1016/s1535-6108(02)00018-1. View

5.
Chow V, Quek H, Tock E . Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line. Cancer Lett. 1993; 73(2-3):141-8. DOI: 10.1016/0304-3835(93)90256-9. View